AI ScreeningAI ChatPricing
  1. US-listed companies
  2. U.S. Stem Cell, Inc.
  3. Financials
  4. Net income margin (%)

U.S. Stem Cell, Inc.【USRM】

Market cap
$64.15K
P/E ratio
SummaryFinancials
Period EndNet income margin (%) YoY (%)
Dec 31, 2022-3,483.2+112.71%
Dec 31, 2021-1,637.6+56.98%
Dec 31, 2020-1,043.2+3135.55%
Dec 31, 2018-32.2-48.88%
Dec 31, 2017-63.1-6.08%
Dec 31, 2016-67.1-10.39%
Dec 31, 2015-74.9-31.64%
Dec 31, 2014-109.6-52.37%
Dec 31, 2013-230.2-27.25%
Dec 31, 2012-316.3-18.61%
Dec 31, 2011-388.7

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)